We suggest that TGF-β1 expression is likely to be significantly stronger in patients with MIA than in those with AIS, and the increased expression may be associated with minimal invasion and infiltration of the myofibroblastic stroma. The gene discussed is TGFB1; the disease is androgen insensitivity syndrome.